Harpreet S. Dhaliwal serves as Executive at Vaxcyte, Inc., where they oversee executive responsibilities. Since joining the company, Harpreet S. Dhaliwal has executed 7 insider transactions totaling $0, demonstrating a balanced approach to their equity position. Their most recent transaction on Sep 8, 2025 involved selling 1,204 shares valued at $39.0K.
Harpreet S. Dhaliwal currently holds 33,670 shares of Vaxcyte, Inc. (PCVX), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Harpreet S. Dhaliwal has been a net neutral trader of PCVX stock. They have purchased $0 and sold $0 worth of shares.
Harpreet S. Dhaliwal's most recent insider trade was on Sep 8, 2025, when they sold 1,204 shares at $32.41 per share.
Get notified when new Form 4 filings are submitted
| $31.56 |
| Discretionary |
| Sep 2, 2025 | PCVX | $14.6K | Payment | 464 | $31.56 | Discretionary |
| Sep 2, 2025 | PCVX | $24.7K | Payment | 783 | $31.56 | Discretionary |
| Dec 28, 2022 | PCVX | $100.0K | Option Exercise | 3,990 | $25.06 | Discretionary |
| Sep 2, 2022 | PCVX | $39.9K | Payment | 1,513 | $26.38 | Discretionary |
| Mar 2, 2022 | PCVX | $0 | Award | 17,500 | $N/A | Discretionary |